当前位置：
X-MOL 学术
›
Nat. Rev. Drug. Disc.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Opportunities for therapeutic antibodies directed at G-protein-coupled receptors
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2017-09-01 , DOI: 10.1038/nrd.2017.173 Catherine J. Hutchings , Markus Koglin , William C. Olson , Fiona H. Marshall
Nature Reviews Drug Discovery ( IF 120.1 ) Pub Date : 2017-09-01 , DOI: 10.1038/nrd.2017.173 Catherine J. Hutchings , Markus Koglin , William C. Olson , Fiona H. Marshall
Nature Reviews Drug Discovery16 (2017)In the article, the clinical trial for the biparatopic CXCR2 nanobody was described as being for cancer instead of inflammation. This error has been corrected in the online version.
中文翻译：
针对G蛋白偶联受体的治疗性抗体的机会
Nature Reviews Drug Discovery16（2017）在文章中，双对位CXCR2纳米抗体的临床试验被描述为用于癌症而非炎症。在线版本中，此错误已得到纠正。
更新日期：2017-09-04
中文翻译：
针对G蛋白偶联受体的治疗性抗体的机会
Nature Reviews Drug Discovery16（2017）在文章中，双对位CXCR2纳米抗体的临床试验被描述为用于癌症而非炎症。在线版本中，此错误已得到纠正。
京公网安备 11010802027423号